Cargando…
The anti‐inflammatory compound palmitoylethanolamide inhibits prostaglandin and hydroxyeicosatetraenoic acid production by a macrophage cell line
The anti‐inflammatory agent palmitoylethanolamide (PEA) reduces cyclooxygenase (COX) activity in vivo in a model of inflammatory pain. It is not known whether the compound reduces prostaglandin production in RAW264.7 cells, whether such an action is affected by compounds preventing the breakdown of...
Autores principales: | Gabrielsson, Linda, Gouveia‐Figueira, Sandra, Häggström, Jenny, Alhouayek, Mireille, Fowler, Christopher J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5368964/ https://www.ncbi.nlm.nih.gov/pubmed/28357126 http://dx.doi.org/10.1002/prp2.300 |
Ejemplares similares
-
Palmitoylethanolamide for the treatment of pain: pharmacokinetics, safety and efficacy
por: Gabrielsson, Linda, et al.
Publicado: (2016) -
Relative Deficiency of Anti-Inflammatory N-Acylethanolamines Compared to Prostaglandins in Oral Lichen Planus
por: Rankin, Linda, et al.
Publicado: (2020) -
Effects of tumour necrosis factor α upon the metabolism of the endocannabinoid anandamide in prostate cancer cells
por: Karlsson, Jessica, et al.
Publicado: (2017) -
The Basal Pharmacology of Palmitoylethanolamide
por: Rankin, Linda, et al.
Publicado: (2020) -
Satiety Factors Oleoylethanolamide, Stearoylethanolamide, and Palmitoylethanolamide in Mother’s Milk Are Strongly Associated with Infant Weight at Four Months of Age—Data from the Odense Child Cohort
por: Bruun, Signe, et al.
Publicado: (2018)